Abstract
Our findings continue to indicate that lumpectomy followed by breast irradiation is appropriate therapy for women with either negative or positive axillary nodes and breast tumors 4 cm or less in diameter.
Keywords
MeSH Terms
Affiliated Institutions
Related Publications
A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
We conducted a randomized, double-blind, placebo-controlled trial of postoperative therapy with tamoxifen (10 mg twice a day) in 2644 patients with breast cancer, histologically...
Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials
<p><strong>Background</strong>\nRandomized trials of radiotherapy and surgery for early breast cancer may have been too small to detect differences in long-ter...
Abreast in a boat--a race against breast cancer.
Many patients trying to get back to “real life” after a serious illness are disheartened to find that the post-treatment phase of their care is sadly wanting. Survivors of breas...
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Some months of adjuvant polychemotherapy (eg, with CMF or an anthracycline-containing regimen) typically produces an absolute improvement of about 7-11% in 10-year survival for ...
Randomized Trial of Two Versus Five Years of Adjuvant Tamoxifen for Postmenopausal Early Stage Breast Cancer
Five years of adjuvant tamoxifen is more beneficial than 2 years in the treatment of postmenopausal women with estrogen receptor-positive, early stage, invasive breast cancer.
Publication Info
- Year
- 1995
- Type
- article
- Volume
- 333
- Issue
- 22
- Pages
- 1456-1461
- Citations
- 1459
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1056/nejm199511303332203
- PMID
- 7477145